PHAT CIK: 1783183

Phathom Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
0
FY23:
0.52
FY24:
47.3
FY25:
153
(positive)
Change from FY21 to FY25
millions USD
FY21:
−135
FY22:
−172
FY23:
−167
FY24:
−277
FY25:
−160
(positive)
Change from FY21 to FY25
millions USD
FY21:
−137
FY22:
−170
FY23:
−159
FY24:
−262
FY25:
−152
(positive)
Change from FY21 to FY25
millions USD
FY21:
−144
FY22:
−198
FY23:
−202
FY24:
−334
FY25:
−221
(positive)
Change from FY21 to FY25
millions USD
FY21:
−144
FY22:
−198
FY23:
−202
FY24:
−334
FY25:
−221

All amounts in millions USD Data sources:SEC EDGARTwelve Data